GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » D. Western Therapeutics Institute Inc (TSE:4576) » Definitions » Beneish M-Score

D. Western Therapeutics Institute (TSE:4576) Beneish M-Score : -2.39 (As of Mar. 30, 2025)


View and export this data going back to 2013. Start your Free Trial

What is D. Western Therapeutics Institute Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.39 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for D. Western Therapeutics Institute's Beneish M-Score or its related term are showing as below:

TSE:4576' s Beneish M-Score Range Over the Past 10 Years
Min: -9.19   Med: -2.43   Max: 1009.08
Current: -2.39

During the past 13 years, the highest Beneish M-Score of D. Western Therapeutics Institute was 1009.08. The lowest was -9.19. And the median was -2.43.


D. Western Therapeutics Institute Beneish M-Score Historical Data

The historical data trend for D. Western Therapeutics Institute's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

D. Western Therapeutics Institute Beneish M-Score Chart

D. Western Therapeutics Institute Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.57 -2.09 -2.46 -3.30 -2.39

D. Western Therapeutics Institute Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -3.30 - - -2.39

Competitive Comparison of D. Western Therapeutics Institute's Beneish M-Score

For the Biotechnology subindustry, D. Western Therapeutics Institute's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


D. Western Therapeutics Institute's Beneish M-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, D. Western Therapeutics Institute's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where D. Western Therapeutics Institute's Beneish M-Score falls into.


;
;

D. Western Therapeutics Institute Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of D. Western Therapeutics Institute for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9695+0.528 * 1.0153+0.404 * 1.1534+0.892 * 1.1009+0.115 * 1.0178
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1+4.679 * 0.005279-0.327 * 1.2116
=-2.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec24) TTM:Last Year (Dec23) TTM:
Total Receivables was 円125.0 Mil.
Revenue was 円471.6 Mil.
Gross Profit was 円424.7 Mil.
Total Current Assets was 円1,475.4 Mil.
Total Assets was 円1,669.4 Mil.
Property, Plant and Equipment(Net PPE) was 円11.2 Mil.
Depreciation, Depletion and Amortization(DDA) was 円49.3 Mil.
Selling, General, & Admin. Expense(SGA) was 円0.0 Mil.
Total Current Liabilities was 円132.6 Mil.
Long-Term Debt & Capital Lease Obligation was 円778.9 Mil.
Net Income was 円-1,290.3 Mil.
Gross Profit was 円0.0 Mil.
Cash Flow from Operations was 円-1,299.1 Mil.
Total Receivables was 円117.1 Mil.
Revenue was 円428.4 Mil.
Gross Profit was 円391.7 Mil.
Total Current Assets was 円2,138.0 Mil.
Total Assets was 円2,373.4 Mil.
Property, Plant and Equipment(Net PPE) was 円10.0 Mil.
Depreciation, Depletion and Amortization(DDA) was 円48.7 Mil.
Selling, General, & Admin. Expense(SGA) was 円0.0 Mil.
Total Current Liabilities was 円194.0 Mil.
Long-Term Debt & Capital Lease Obligation was 円875.6 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(125.023 / 471.58) / (117.144 / 428.364)
=0.265115 / 0.273468
=0.9695

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(391.697 / 428.364) / (424.736 / 471.58)
=0.914402 / 0.900666
=1.0153

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1475.382 + 11.192) / 1669.444) / (1 - (2137.959 + 10.01) / 2373.371)
=0.109539 / 0.094971
=1.1534

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=471.58 / 428.364
=1.1009

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(48.721 / (48.721 + 10.01)) / (49.329 / (49.329 + 11.192))
=0.829562 / 0.815072
=1.0178

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 471.58) / (0 / 428.364)
=0 / 0
=1

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((778.928 + 132.646) / 1669.444) / ((875.598 + 194.008) / 2373.371)
=0.546034 / 0.45067
=1.2116

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-1290.305 - 0 - -1299.118) / 1669.444
=0.005279

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

D. Western Therapeutics Institute has a M-score of -2.39 suggests that the company is unlikely to be a manipulator.


D. Western Therapeutics Institute Beneish M-Score Related Terms

Thank you for viewing the detailed overview of D. Western Therapeutics Institute's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


D. Western Therapeutics Institute Business Description

Traded in Other Exchanges
N/A
Address
7th Floor, 18 KT Bulding, 1-18-11, Nishiki, Naka-ku, Aichi, Nagoyashi, JPN, 460-0003
D. Western Therapeutics Institute Inc is engaged in the research and development of pharmaceutical drugs in Japan. Its products include ophthalmic solution and agents for antiplatelet and anti-glaucoma.

D. Western Therapeutics Institute Headlines

No Headlines